Company intelligence / Profile preview
Tikun Therapeutics
New York, New York, United States
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Tikun Therapeutics is a clinical-stage pharmaceutical company dedicated to developing and commercializing cannabinoid-based therapies for patients with significant unmet medical needs. The company leverages over a decade of clinical data and proprietary genetics from its affiliate, Tikun Olam, to advance a pipeline of standardized cannabinoid medicines. Its lead candidate, Avidekel, is a high-CBD, low-THC formulation currently being evaluated in Phase 2 clinical trials for indications such as Crohn's disease, Autism Spectrum Disorder, and Epidermolysis Bullosa. By applying pharmaceutical-grade standards to cannabinoid research, Tikun Therapeutics aims to provide evidence-based treatments that are safe and effective. The company is headquartered in New York and operates with a focus on rigorous scientific validation.
- Therapeutic areas
- GastroenterologyDermatologyPsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Tikun Olam
Beyond the preview
Go deeper on Tikun Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tikun Therapeutics.